Abstract PO-053: Targeting focal adhesions to limit radiation-induced glioblastoma cell invasion

Author(s):  
Lisa R. Decotret ◽  
Rocky Shi ◽  
Kevin L. Bennewith
Cells ◽  
2021 ◽  
Vol 10 (2) ◽  
pp. 388
Author(s):  
Brice Chanez ◽  
Kevin Ostacolo ◽  
Ali Badache ◽  
Sylvie Thuault

Regulation of microtubule dynamics by plus-end tracking proteins (+TIPs) plays an essential role in cancer cell migration. However, the role of +TIPs in cancer cell invasion has been poorly addressed. Invadopodia, actin-rich protrusions specialized in extracellular matrix degradation, are essential for cancer cell invasion and metastasis, the leading cause of death in breast cancer. We, therefore, investigated the role of the End Binding protein, EB1, a major hub of the +TIP network, in invadopodia functions. EB1 silencing increased matrix degradation by breast cancer cells. This was recapitulated by depletion of two additional +TIPs and EB1 partners, APC and ACF7, but not by the knockdown of other +TIPs, such as CLASP1/2 or CLIP170. The knockdown of Focal Adhesion Kinase (FAK) was previously proposed to similarly promote invadopodia formation as a consequence of a switch of the Src kinase from focal adhesions to invadopodia. Interestingly, EB1-, APC-, or ACF7-depleted cells had decreased expression/activation of FAK. Remarkably, overexpression of wild type FAK, but not of FAK mutated to prevent Src recruitment, prevented the increased degradative activity induced by EB1 depletion. Overall, we propose that EB1 restricts invadopodia formation through the control of FAK and, consequently, the spatial regulation of Src activity.


2019 ◽  
Vol 21 (Supplement_6) ◽  
pp. vi30-vi30
Author(s):  
Roland Kälin ◽  
Giorgia Mastrella ◽  
Mengzhuo Hou ◽  
Min Li ◽  
Veit Stoecklein ◽  
...  

Abstract Anti-angiogenic therapy of glioblastoma with bevacizumab, a vascular endothelial growth factor-A (VEGFA) blocking antibody, may accelerate tumor cell invasion and induce alternative angiogenic pathways. We investigated the roles of the pro-angiogenic receptor APLNR and its cognate ligand apelin in VEGFA/VEGFR2 anti-angiogenic therapy against distinct subtypes of glioblastoma. In proneural glioblastoma, apelin levels were downregulated by VEGFA or VEGFR2 blockade by use of bevacizumab or ramucirumab, respectively. A central role for apelin/APLNR in controlling glioblastoma vascularization was corroborated in a serial implantation model of the angiogenic switch that occurs in human glioblastoma. Apelin and APLNR are broadly expressed in human glioblastoma, and knockdown or knockout of APLN in orthotopic models of proneural or classical glioblastoma subtypes massively reduced glioblastoma vascularization as compared with controls. What is more, direct infusion of the bioactive peptide apelin-13 was able to rescue this vascular loss-of-function phenotype, demonstrating the specific control of tumor vascularization by apelin/APLNR signaling. While high levels of apelin correlated with reduced tumor cell invasiveness, the reduction in apelin expression led to accelerated glioblastoma cell invasion. Analysis of stereotactic glioblastoma biopsies from patients as well as from in vitro and in vivo experiments revealed increased dissemination of APLNR-positive tumor cells when apelin levels were reduced. Most interestingly, application of apelin-F13A, a mutant APLNR ligand, blocked both tumor angiogenesis and glioblastoma cell invasion. Furthermore, co-targeting VEGFR2 and APLNR synergistically improved survival of mice bearing proneural glioblastoma. In summary, we show that apelin/APLNR signaling controls glioblastoma angiogenesis and invasion directly, and that both pathological features are blunted by apelin-F13A. We suggest that apelin-F13A can improve the efficiency and reduce the side effects of established anti-angiogenic treatments for distinct glioblastoma subtypes.


2017 ◽  
Vol 16 (2) ◽  
pp. 322-332 ◽  
Author(s):  
Zonghui Ding ◽  
Alison Roos ◽  
Jean Kloss ◽  
Harshil Dhruv ◽  
Sen Peng ◽  
...  

2018 ◽  
Vol 423 ◽  
pp. 86-94 ◽  
Author(s):  
Yu-Shui Ma ◽  
Zhi-Jun Wu ◽  
Rui-Zhen Bai ◽  
Hua Dong ◽  
Bing-Xue Xie ◽  
...  

Neoplasia ◽  
2018 ◽  
Vol 20 (10) ◽  
pp. 1045-1058 ◽  
Author(s):  
Zonghui Ding ◽  
Harshil Dhruv ◽  
Aneta Kwiatkowska-Piwowarczyk ◽  
Rosamaria Ruggieri ◽  
Jean Kloss ◽  
...  

2010 ◽  
Author(s):  
Matthew J. Ennis ◽  
Wendy S. McDonough ◽  
Amanda Chan ◽  
Marc H. Symons ◽  
Jeffrey A. Winkles ◽  
...  

2018 ◽  
Vol 20 (suppl_6) ◽  
pp. vi28-vi28
Author(s):  
Zonghui Ding ◽  
Zhiwan Dong ◽  
Yuping Yang ◽  
Shannon Fortin-Ensign ◽  
Hemragul Sabit ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document